Cargando…

Focusing on caveolin-1 in CNS autoimmune disease: multiple sclerosis

Detalles Bibliográficos
Autores principales:	Wu, Hao, Shen, Jiangang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270425/ https://www.ncbi.nlm.nih.gov/pubmed/28197183 http://dx.doi.org/10.4103/1673-5374.197129

Ejemplares similares

Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Pallais, Jean Pierre, et al.
Publicado: (2019)

Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis
por: Pearse, Damien D., et al.
Publicado: (2021)

Multiple sclerosis: why we should focus on both sides of the (auto) antibody
por: den Dunnen, Jeroen, et al.
Publicado: (2021)

Caveolin-1 as a target in prevention and treatment of hypertrophic scarring
por: Kruglikov, Ilja L., et al.
Publicado: (2019)

Caveolin-1 in sarcomas: friend or foe?
por: Sáinz-Jaspeado, Miguel, et al.
Publicado: (2011)

Neuroprotective effects of vascular endothelial growth factor A in the experimental autoimmune encephalomyelitis model of multiple sclerosis
por: Lin, Wensheng
Publicado: (2017)

Caveolin-1, cellular senescence and pulmonary emphysema
por: Volonte, Daniela, et al.
Publicado: (2009)

Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
por: Fischer, Aryeh, et al.
Publicado: (2019)

Multiple Sclerosis: Overview of Disease-Modifying Agents
por: Finkelsztejn, Alessandro
Publicado: (2014)

The Role of Optical Coherence Tomography in Differential Diagnosis of Multiple Sclerosis and Autoimmune Connective Tissue Diseases with CNS Involvement
por: Wildner, Paula, et al.
Publicado: (2020)

Interactive mechanisms between caveolin-1 and actin filaments or vimentin intermediate filaments instruct cell mechanosensing and migration
por: Tang, Daijiao, et al.
Publicado: (2022)

Potassium channel blockers restore axonal conduction in CNS trauma and diseases
por: Page, Jessica C., et al.
Publicado: (2016)

Emerging role of neuregulin-1beta1 in pathogenesis and progression of multiple sclerosis
por: Ziaee, Seyyed Mohyeddin, et al.
Publicado: (2022)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Targeting metabolism to treat multiple sclerosis
por: Bhargava, Pavan
Publicado: (2020)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Treg in CNS autoimmune disease
por: Anderton, Stephen M
Publicado: (2012)

Is Multiple Sclerosis an Autoimmune Disease?
por: Wootla, Bharath, et al.
Publicado: (2012)

Acoustic Waves in Axonal Membrane and Caveolins are the New Targets for Pain Treatment with High Frequency Ultrasound
por: Kruglikov, Ilja
Publicado: (2020)

Skeletal muscle activity and CNS neuro-plasticity
por: Zhorne, Rachel, et al.
Publicado: (2016)

Perspectives on neuroreparative therapies for treating multiple sclerosis
por: Xiao, Junhua
Publicado: (2015)

Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020)

Immunological role of sulfatide in the pathogenesis of multiple sclerosis
por: Hamatani, Mio, et al.
Publicado: (2023)

Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis
por: Yoon, Naeun, et al.
Publicado: (2021)

Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases
por: Yokote, Hiroaki, et al.
Publicado: (2016)

Pannexin 1-based channels activity as a novel regulator of multiple sclerosis progression
por: Ortiz, Fernando C., et al.
Publicado: (2019)

Ependymal cells and multiple sclerosis: proposing a relationship
por: Hatrock, Dale, et al.
Publicado: (2019)

Developmental transcription factors in age-related CNS disease: a phoenix rising from the ashes?
por: White, Robert B., et al.
Publicado: (2016)

Antibody-based Validation of CNS Ion Channel Drug Targets
por: Rhodes, Kenneth J., et al.
Publicado: (2008)

Genetically modifying transcription factors to promote CNS axon regeneration
por: Mehta, Saloni T., et al.
Publicado: (2017)

Salvaging CNS Clinical Trials Halted Due to COVID‐19
por: Geerts, Hugo, et al.
Publicado: (2020)

Galectin-3 prospects as a therapeutic agent for multiple sclerosis
por: Thomas, Laura, et al.
Publicado: (2019)

Myelin positron emission tomography (PET) imaging in multiple sclerosis
por: de Paula Faria, Daniele
Publicado: (2020)

The Importance of the Cognitive Aspects of Vocational Rehabilitation for Individuals With Multiple Sclerosis
por: Kennedy, Winston, et al.
Publicado: (2020)

Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammation
por: Ciolac, Dumitru, et al.
Publicado: (2022)

Trans-synaptic degeneration as a mechanism of neurodegeneration in multiple sclerosis
por: Murphy, Olwen C., et al.
Publicado: (2023)

Autoimmunity – Multiple Sclerosis
por: Ances, Beau M., et al.
Publicado: (2005)

Intracellular compartmentation of cAMP promotes neuroprotection and regeneration of CNS neurons
por: Cameron, Evan G., et al.
Publicado: (2017)

Environmental enrichment as a promising strategy for aiding multiple sclerosis treatment
por: Silva, Berenice Anabel, et al.
Publicado: (2020)

Role of CD20(+) T cells in multiple sclerosis: implications for treatment with ocrelizumab
por: Gingele, Stefan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m53jq9id4t804n14nj2m75skq0